Our Anyfusion cylinder pumps, as well as our traditional horizontal infusion pumps, had many air alarm issues.

In many ICUs and wards where a single patient uses multiple pumps for 3-4 days, rather than in NICUs where a single patient uses 2-3 pumps per day and only one cartridge per pump, air alarms from each pump have been a major issue for purchasing and acceptance. Recently, Israel's B-pump was the smallest pump in the market, but it was withdrawn from the market due to too many air alarm issues. In addition, despite product training, the biggest issue that led to rejections was the random shutdown of the screen due to the crash of the operating program without fully understanding the product.

There were many issues that did not occur in the NICU, and it was necessary to overcome them. The world's largest pump companies have experienced these issues in the clinical field for decades and have overcome them to reach the present, but Air alarm has not been able to overcome the problem of the original technology.

We have upgraded the program and tested it in the lab, but after testing the Anyfusion cylinder pump for two weeks with four days of air alarms, we did not encounter any. Air alarms can be reproduced, but screen freezes cannot be reproduced, so we upgraded to S/W defense processing.

We decided to conduct a re-demo at Incheon S Hospital, where the above two issues were problematic, and verify it. After the verification of S Hospital, it will be verified at Gangbuk S Hospital and Suwon A Hospital, and then demoed at S University Hospital, the best major hospital. Once verified in the domestic real world, we will start the challenge for a global game changer. This is because it is expected to be highly competitive in the U.S. market, which emphasizes eye care with a pump that is clinically safe and secure. .

The original technology of the existing pump may not have been possible, but Anyfusion is the original technology that can solve this problem, and the Anyfusion cylinder pump is a technology that will become a global game changer because it is not divided into two pumps, but a single pump and a single set with perfect clinical safety and effectiveness, convenience and cost-effectiveness.

I would like to congratulate the R&D department for their hard work for the upgrade.

Thank you.